Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-004945
Filing Date
2022-06-08
Accepted
2022-06-08 18:38:22
Documents
1
Period of Report
2022-06-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4162
  Complete submission text file 0001562180-22-004945.txt   5571
Mailing Address C/O LOXO ONCOLOGY, INC. ONE LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address
Bilenker Joshua H. (Reporting) CIK: 0001612312 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39941 | Film No.: 221004540

Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)